menu search

NBY / NovaBay Pharmaceuticals to Hold First Quarter 2022 Conference Call on May 12

NovaBay Pharmaceuticals to Hold First Quarter 2022 Conference Call on May 12
EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that it will report financial results for the three months ended March 31, 2022 after market close on Thursday, May 12, 2022 and will hold an investment community conference call that day beginning at 4:30 p.m. Eastern time. Date/Time:   Thursday, May 12, 4:30 p.m. ET / 1:30 p.m. PT       Pre-Registration:   Participants can pre-register for the conference call here:     Callers who pre-register w Read More
Posted: May 5 2022, 06:50
Author Name: Business Wire
Views: 110594

NBY News  

NovaBay Pharmaceuticals to Hold Third Quarter 2023 Conference Call on November 9, 2023

By Business Wire
November 2, 2023

NovaBay Pharmaceuticals to Hold Third Quarter 2023 Conference Call on November 9, 2023

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that it will report financial results for the thre more_horizontal

NovaBay Pharmaceuticals to Present at the Dawson James Small Cap Growth Conference

By Business Wire
October 2, 2023

NovaBay Pharmaceuticals to Present at the Dawson James Small Cap Growth Conference

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay Pharmaceuticals, Inc. (NYSE American: NBY), a company developing and commercializing high-quality eyecare more_horizontal

NovaBay Pharmaceuticals, Inc. (NBY) Q2 2023 Earnings Call Transcript

By Seeking Alpha
August 12, 2023

NovaBay Pharmaceuticals, Inc. (NBY) Q2 2023 Earnings Call Transcript

NovaBay Pharmaceuticals, Inc. (NYSE:NBY ) Q2 2023 Earnings Conference Call August 10, 2023 4:30 PM ET Company Participants Jody Cain - LHA, IR Justin more_horizontal

NovaBay Pharmaceuticals to Present at the Emerging Growth Virtual Conference on May 31, 2023

By Business Wire
May 24, 2023

NovaBay Pharmaceuticals to Present at the Emerging Growth Virtual Conference on May 31, 2023

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a company developing and commercializing high-quality eyeca more_horizontal

Looking for Undervalued Penny Stocks? Use These Tips

By PennyStocks
May 22, 2023

Looking for Undervalued Penny Stocks? Use These Tips

Understanding the stock market can be a challenging endeavor, yet it offers vast potential for substantial gains, particularly when it comes to penny more_horizontal

Penny Stock Investing, 3 High-Growth Industries to Watch

By PennyStocks
May 21, 2023

Penny Stock Investing, 3 High-Growth Industries to Watch

Take a look at these 3 industries to find penny stocks in The post Penny Stock Investing, 3 High-Growth Industries to Watch appeared first on Penny St more_horizontal

NovaBay Pharmaceuticals to Hold First Quarter 2023 Conference Call on May 11, 2023

By Business Wire
May 4, 2023

NovaBay Pharmaceuticals to Hold First Quarter 2023 Conference Call on May 11, 2023

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that it will report financial results for the thre more_horizontal

NovaBay Pharmaceuticals, Inc. (NBY) Q4 2022 Earnings Call Transcript

By Seeking Alpha
March 30, 2023

NovaBay Pharmaceuticals, Inc. (NBY) Q4 2022 Earnings Call Transcript

NovaBay Pharmaceuticals, Inc. (NYSE:NBY ) Q4 2022 Earnings Conference Call March 30, 2023 4:30 PM ET Company Participants Jody Cain - Investor Relatio more_horizontal


Search within

Pages Search Results: